Amgen Inc. buy The Goldman Sachs Group, Inc.
Start price
05.11.25
/
50%
€268.25
Target price
05.11.26
€348.04
Performance (%)
4.06%
Price
18.12.25
€276.75
Summary
This prediction is currently active. With a performance of 4.06%, the BUY prediction by The_Goldman_Sachs_Gr for Amgen Inc. is trending in the right direction. Dividends of €2.38 are taken into consideration when calculating the performance. This prediction currently runs until 05.11.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 2.386% | 2.386% |
| iShares Core DAX® | -0.793% | 4.201% |
| iShares Nasdaq 100 | -2.376% | 0.857% |
| iShares Nikkei 225® | -2.701% | -0.147% |
| iShares S&P 500 | -1.689% | 1.244% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $405.00 to $400.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat